Bvunza1

CAT # Product Name Tsanangudzo
CPD100608 ASK1-Inhibitor-10 ASK1 Inhibitor 10 is an olly bioavailable inhibitor yeapoptosis signal-regulating kinase 1 (ASK1). Inosarudza ASK1 pamusoro peASK2 uyewo MEKK1, TAK-1, IKKβ, ERK1, JNK1, p38α, GSK3β, PKCθ, uye B-RAF. Inodzivisa kuwedzera kwe streptozotocin-induced muJNK uye p38 phosphorylation mu INS-1 pancreatic β masero muhutano-hunoenderana.
CPD100607 K811 K811 inonzi ASK1-specific inhibitor inorebesa kurarama mumhando yembeva yeamyotrophic lateral sclerosis. K811 yakanyatso dzivirira kupararira kwesero mumitsetse yemasero ane yakakwira ASK1 kutaura uye muHER2-overexpressing GC masero. Kurapa neK811 kwakaderedzwa hukuru hwemamota exenograft nekudzikisira mamaki ekuwedzera.
CPD100606 K812 K812 inonzi ASK1-specific inhibitor yakawanikwa kuti irebese kurarama mumhando yembeva yeamyotrophic lateral sclerosis.
CPD100605 MSC-2032964A MSC 2032964A ine simba uye inosarudza ASK1 inhibitor (IC50 = 93 nM). Iyo inovhara LPS-induced ASK1 uye p38 phosphorylation mune yakasimwa mbeva astrocytes uye inodzvanya neuroinflammation mune mbeva EAE modhi. MSC 2032964A inowanikwa nemuromo uye inopinda muuropi.
CPD100604 Selonsertib Selonsertib, inozivikanwawo se GS-4997, inonzi orally bioavailable inhibitor yeapoptosis signal-regulating kinase 1 (ASK1), ine zvinogona anti-inflammatory, antineoplastic uye anti-fibrotic zviitiko. GS-4997 inotarisa uye inosungira kune catalytic kinase domain ye ASK1 nenzira yeATP-yemakwikwi, nokudaro ichidzivirira phosphorylation uye activation. GS-4997 inodzivirira kugadzirwa kweanopisa cytokines, pasi-inogadzirisa kutaura kwemajini anobatanidzwa mufibrosis, inodzvinyirira yakawandisa apoptosis uye inhibits kupararira kwesero.
...

Taura nesu

Inquiry

Latest News

  • Pamusoro 7 Trends MuKutsvaga Kwemishonga Muna 2018

    Epamusoro 7 Mafambiro Mukutsvakurudza Kwemishonga Ini...

    Kuve pasi pekumanikidzwa kunoramba kuchiwedzera kukwikwidza munzvimbo yakaoma yehupfumi uye tekinoroji, makambani emishonga uye ebiotech anofanirwa kuramba achivandudza muzvirongwa zvavo zveR&D kuti varambe vari mberi ...

  • ARS-1620: Inovimbisa inhibitor itsva yeKRAS-mutant cancers

    ARS-1620: Inhibitor itsva inovimbisa yeK...

    Zvinoenderana neongororo yakaburitswa muSero, vaongorori vakagadzira chaiyo inhibitor yeKRASG12C inonzi ARS-1602 iyo yakakonzera kudzoka kwebundu mumakonzo. "Chidzidzo ichi chinopa in vivo humbowo hwekuti mutant KRAS inogona ...

  • AstraZeneca inogamuchira kukwidziridzwa kwemishonga yeoncology

    AstraZeneca inogamuchira kukwidziridzwa kwe ...

    AstraZeneca yakagamuchira kukwidziridzwa kwakapetwa kaviri kweiyo oncology portfolio neChipiri, mushure mekunge US neEuropean regulators vabvuma kutumirwa kwemishonga yavo, danho rekutanga rekuhwina mvumo yemishonga iyi. ...

WhatsApp Online Chat !